METHOD FOR TREATING ACUTE EXPERIMENTAL PANCREATITIS

摘要

The method for treating the acute experimental pancreatitis provides for intravenous administration of the liposomal form of Dalargin at a dose of 0.002-0.003 g and Sandostatin at a dose of 0.2-0.3 mg in combination with intrabursal administration of Deltaran at a dose of 0.0009-0.0012 g and intra-arterial administration of free form of Dalargin at a dose of 0.001-0.002 g and Sandostatin at a dose of 0.1-0.2 mg into the celiac trunk for 2-3 days.